Obstructive sleep apnoea in the elderly: Recognition and management considerations

Drugs and Aging

Volumn 21, Issue 5, 2004, Pages 307-322

  Quinnell, Timothy G ^a   Smith, Ian E ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALCOHOL; CLONIDINE; PLACEBO; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGING; AIRWAY OBSTRUCTION; ANAMNESIS; ANTICHOLINERGIC EFFECT; CHEYNE STOKES BREATHING; CLINICAL EXAMINATION; CONSERVATIVE TREATMENT; CONSTIPATION; CORRELATION ANALYSIS; DEPRESSION; DEVICE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INDICATION; DRUG SAFETY; HUMAN; IMPOTENCE; METABOLIC ACIDOSIS; OBESITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SLEEP APNEA SYNDROME; SNORING; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT INDICATION; URINARY HESITANCY; WEIGHT REDUCTION; XEROSTOMIA;

AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; QUALITY OF LIFE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; WEIGHT LOSS;

EID: 1942435961     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200421050-00003     Document Type: Review

References (109)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnoea. Am J Respir Crit Care Med 2002; 165: 1217-39
2. George CFP. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001; 56: 508-12
3. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnoea. Am Rev Respir Dis 1988; 138: 337-40
4. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991; 14 (6): 486-95
5. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnoea. J Clin Invest 1995; 96 (4): 1897-904
6. Morgan BJ, Dempsey JA, Pegelow DF, et al. Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep 1998; 21 (7): 737-46
7. Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnoea: implications for hypertension. J Hypertens 1997; 15: 1613-9
8. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89
9. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-10
10. Faccenda JF, Mackay TW, Boon NA, et al. Randomised placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnoea-hypopnoea syndrome. Am J Respir Crit Care Med 2001; 163: 344-8
11. He J, Kryger MH, Zorick FJ, et al. Mortality and apnoea index in obstructive sleep apnoea: experience in 385 male patients. Chest 1988; 94: 9-14
12. Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J 2002; 19: 499-503
13. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5
14. Kim HC, Young T, Matthews CG, et al. Sleep-disordered breathing and neuropsychological deficits. Am J Respir Crit Care Med 1997; 156: 1813-9
15. Hume KI, Van F, Watson A. A field study of age and gender differences in habitual adult sleep. J Sleep Res 1998; 7: 85-94
16. Feinsilver SH, Hertz G. Sleep in the elderly patient. Clin Chest Med 1993; 14: 405-11
17. Findley LJ, Fabrizio MJ, Knight H, et al. Driving simulator performance in patients with sleep apnoea. Am Rev Respir Dis 1989; 140: 529-30
18. Austroads. Sleep disorders. In: Austroads, editor. Assessing fitness to drive: guidelines and standards for health professionals in Australia. 3rd ed. Sydney: Austroads Inc., 2003: 87-91
19. Driver and Vehicle Licensing Agency. Renal and respiratory disorders: at a glance booklet [online]. Available from URL: http://www.dvla.gov.uk/ at_a_glance/ch7_renal_respiratory.htm [Accessed 2004 Feb 1]
20. Pankow W, Nabe B, Lies A, et al. Influence of sleep apnoea on 24-hour blood pressure. Chest 1997; 112 (5): 1253-8
21. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25
22. Lavie P, Herer P, Segev T, et al. Cardiovascular mortality in sleep laboratory patients: excess risk associated with breathing disorders in sleep [abstract]. Sleep 2003; 26 Suppl.: A213
23. Ancoli-Israel S, Klauber MR, Kripke DF, et al. Sleep apnoea in female patients in a nursing home. Chest 1989; 96: 1054-8
24. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep 1996; 19: 275-6
25. Piper AJ, Sullivan CE. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105: 434-40.
26. Hattori H, Hattori C, Yonekura A, et al. Two cases of sleep apnoea syndrome caused by primary hypothyroidism. Acta Otolaryngol Suppl 2003; 550: 59-64
27. Hart TB, Radow SK, Blackard WG, et al. Sleep apnoea in active acromegaly. Arch Intern Med 1985; 145: 865-6
28. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnoea in men. Am J Respir Crit Care Med 1998; 157: 144-8
29. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162: 893-900
30. Elia M. Obesity in the elderly. Obes Res 2001; 9 (4 Suppl.): 244-8S
31. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnoea-hypopnoea and related clinical features in a population-based sample of subjects aged 30 to 70 years. Am J Respir Crit Care Med 2001; 163: 685-9
32. Liu PY, Yee B, Wishart SM, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003; 88: 3605-13
33. Dexter DD, Dovre EJ. Obstructive sleep apnoea due to endogenous testosterone production in a woman. Mayo Clin Proc 1998; 73: 246-8
34. Zhou XS, Rowley JA, Demirovic F, et al. Effect of testosterone on the apneic threshold in women during NREM sleep [abstract]. J Appl Physiol 2003 Jan; 94 (1): 101-7
35. McConnell AK, Copestake AJ. Maximum static respiratory pressures in healthy elderly men and women: issues of reproducibility and interpretation. Respiration 1999; 66: 251-8
36. Grunstein R, Wilcox I, Yang T-S, et al. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes 1993; 17: 533-40
37. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991; 46: 85-90
38. Flemons WW, Whitelaw WA, Brant R, et al. Likelihood ratios for a sleep apnoea clinical prediction rule. Am J Respir Crit Care Med 1994, 85
39. Stradling JR. Obstructive sleep apnoea: definitions, epidemiology, and natural history. Thorax 1995; 50: 683-9
40. Strohl KP, Redline S. Recognition of obstructive sleep apnoea. Am J Respir Crit Care Med 1996; 154: 279-89
41. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163: 608-13
42. Ayala C, Cozar MV, Rodriguez JR, et al. Subclinical thyroid disease in institutionalised healthy geriatric population [in Spanish]. Med Clin (Barc) 2001; 117: 534-5
43. Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnoea. Am J Respir Crit Care Med 1999; 160: 732-5
44. Mezon BJ, West P, MaClean JP, et al. Sleep apnoea in acromegaly. Am J Med 1980; 69: 615-8
45. Perks WH, Horrocks PM, Cooper RA, et al. Sleep apnoea in acromegaly. BMJ 1980; 280: 894-7
46. Issa FG, Sullivan CE. Alcohol, snoring and sleep apnoea. J Neurol Neurosurg Psychiatry 1982; 45: 353-9
47. Scanlan MF, Roebuck T, Little PJ, et al. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 2000; 16: 909-13
48. Teschler H, Berthon-Jones M, Wessendorf T, et al. Influence of moderate alcohol consumption on obstructive sleep apnoea with and without autoset nasal CPAP therapy. Eur Respir J 1996; 9: 2371-7
49. Robinson RW, White DP, Zwillich CW. Moderate alcohol ingestion increases upper airway resistance in normal subjects. Am Rev Respir Dis 1985; 132: 1238-41
50. Office of Population Censuses and Surveys. Health survey for England 1993. London: Her Majesty's Stationery Office, 1995
51. Barrick C, Connors GJ. Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders. Drugs Aging 2002; 19: 583-94
52. Raiha I, Seppala M, Impivaara O, et al. Chronic illness and subjective quality of sleep in the elderly. Aging (Milano) 1994; 6: 91-6
53. Asplund R. Sleep disorders in the elderly. Drugs Aging 1999; 14: 91-103
54. Meguro K, Ueda M, Kobayashi I, et al. Sleep disturbance in elderly patients with cognitive impairment, decreased daily activity and periventricular white matter lesions. Sleep 1995; 18: 109-14
55. Foley DJ, Monjan AA, Masaki KH, et al. Associations of symptoms of sleep apnoea with cardiovascular disease, cognitive impairment, and mortality among older Japanese-American men. J Am Geriatr Soc 1999; 47: 524-8
56. Ancoli-Israel S, Klauber MR, Butters N, et al. Dementia in institutionalised elderly: relation to sleep apnoea. J Am Geriatr Soc 1991; 39: 258-63
57. Strollo PJ, Rogers RM. Obstructive sleep apnoea. N Engl J Med 1996; 334: 99-104
58. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5
59. Friedman M, Tanveri H, La Rosa M, et al. Clinical predictors of obstructive sleep apnoea. Laryngoscope 1999; 109: 1901-7
60. Stradling JR. Polysomnography versus simpler alternatives. In: Stradling JR, editor. Handbook of sleep-related breathing disorders. Oxford: Oxford University Press, 1993: 105-11
61. Chiner E, Signes-Costa J, Arriero JM, et al. Nocturnal oximetry for the diagnosis of the sleep apnoea hypopnoea syndrome: a method to reduce the number of polysomnographies? Thorax 1999; 54: 968-71
62. Vazquez J-C, Tsai WH, Flemons WW, et al. Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea. Thorax 2000; 55: 302-7
63. Ross SD, Sheinhait IA, KJ Harrison, et al. Systematic review and meta-analysis of the literature regarding the diagnosis of sleep apnoea. Sleep 2000; 23: 519-32
64. Management of obstructive sleep apnoea/hypopnoea syndrome in adults. Scottish intercollegiate guidelines network 2003 [online]. Available from URL: http://www.sign.ac.uk [Accessed 2004 Feb 1]
65. Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet 1992; 339: 347-50
66. Ayappa I, Norman RG, Krieger AC, et al. Non-invasive detection of respiratory effort-related arousals by a nasal cannula/pressure transducer system. Sleep 2000; 23: 763-71
67. Hosselet JJ, Norman RG, Ayappa I, et al. Detection of flow limitation with a nasal cannula/pressure transducer system. Am J Respir Crit Care Med 1998; 157: 1461-7
68. Rubinstein I, Colapinto N, Rotstein LE, et al. Improvement in upper airway function after weight loss in patients with obstructive sleep apnoea. Am Rev Respir Dis 1988; 138 (5): 1192-5
69. Sampol G, Munoz X, Sagales MT, et al. Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998; 12: 1156-9
70. National Institute for Clinical Excellence. Guidance on the use of orlistat for the treatment of obesity in adults. Technology Appraisal Guidance No. 22 [online]. Available from URL: http://www.nice.org.uk/docref.asp?.d=15731 [Accessed 2004 Feb 1]
71. National Institute for Clinical Excellence. Guidance on the use of sibutramine for the treatment of obesity in adults. Technology Appraisal Guidance No. 31 [online] Available from URL: http://www.nice.org.uk/docref.asp?. d=23795 [Accessed 2004 Feb 1]
72. Bray GA. Drug treatment of obesity. Rev Endocr Metab Disord 2001; 2: 403-18
73. National Institute for Clinical Excellence. Appraisal consultation document: surgery for people with morbid obesity [online]. Available from URL: http://www.nice.org.uk/article.asp?.a=28700 [Accessed 2004 Feb 1]
74. Hoijer U, Hedner J, Ejnell H, et al. Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J 1994; 7: 2011-5
75. Jokic R, Klimaszewski A, Crossley M, et al. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnoea syndrome. Chest 1999; 115: 771-81
76. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; I (8225): 862-5
77. Jenkinson C, Davies RJ, Mullins R, et al. Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea. QJM 2001; 94: 95-9
78. McFadyen TA, Espie CA, McArdle N, et al. Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J 2001; 18: 996-1002
79. McArdle N, Kingshott R, Engleman HM, et al. Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax 2001; 56: 513-8
80. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnoea. Am Rev Respir Dis 1993; 147: 887-95
81. Pepin JL, Krieger J, Rodenstein D, et al. Effective compliance during the first 3 months of continuous positive airway pressure: a European prospective study of 121 patients. Am J Respir Crit Care Med 1999; 160: 1124-9
82. Chmelik F, Doughty A. Objective measures of compliance in asthma treatment. Ann Allergy 1994; 73: 527-32
83. Evangelista L, Doering LV, Dracup K, et al. Compliance behaviors of elderly patients with advanced heart failure. J Cardiovasc Nurs 2003; 18: 197-206
84. Lee AS, Yen KT, Kaplan J. Compliance of nasal continuous positive airway pressure in elderly patients with obstructive sleep apnoea: a retrospective analysis [abstract]. Chest 2000; 118 (4 Suppl.): 79S
85. Hoy CJ, Vennelle M, Kingshott RN, et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnoea/hypopnoea syndrome? Am J Respir Crit Care Med 1999; 159: 1096-100
86. Aloia MS, Di Dio L, Ilniczky N, et al. Improving compliance with nasal CPAP and vigilance in older adults with OSAHS. Sleep Breath 2001; 5: 13-21
87. Wright J, White J. Continuous positive airway pressure for obstructive sleep apnoea (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 3. Oxford: Update Software, 1999
88. Ferguson KA, Ono T, Lowe AA, et al. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997; 52: 362-8
89. Snoring children, sleep apnoea and tonsillectomy. Drug Ther Bull 1992; 30: 6-7
90. Janson C, Gislason T, Bengtsson H, et al. Long-term follow-up of patients with obstructive sleep apnoea treated with uvulopalatopharyngoplasty. Arch Otolaryngol Head Neck Surg 1997; 123: 257-62
91. Doghramji K, Jabourian ZH, Pilla M, et al. Predictors of outcome for uvulopalatopharyngoplasty. Laryngoscope 1995; 105: 311-4
92. Larsson LH, Carlsson-Nordlander B, Svanborg E. Four-year follow-up after uvulopalatopharyngoplasty in 50 unselected patients with obstructive sleep apnoea syndrome. Laryngoscope 1994; 104: 1362-8
93. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnoea to fluoxetine and protriptyline. Chest 1991; 100: 416-21
94. Brownell L, West P, Sweatmen P, et al. Protriptyline in obstructive sleep apnoea: a double blind trial. N Engl J Med 1982; 307: 1037-42
95. Stepanski E, Conway W, Young D, et al. A double-blind trial of protriptyline in the treatment of sleep apnoea syndrome. Henry Ford Hosp Med J 1988; 36 (1): 5-8
96. Whyte K, Gould G, Airlie A, et al. Role of protriptyline and acetazolamide in the sleep apnoea/hypopnoea syndrome. Sleep 1988; 11: 463-72
97. Smith I, Lasserson T, Wright J. Drug treatments for obstructive sleep apnoea (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2003
98. Wilson SJ, Bailey JE, Alford C, et al. Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood. J Psychopharmacol 2002; 16: 321-31
99. Gentili A, Godschalk MF, Gheorghiu D, et al. Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomised, controlled trial. Eur J Clin Pharmacol 1996; 50: 463-5
100. Issa F. Effect of clonidine in obstructive sleep apnoea. Am Rev Respir Dis 1992; 145: 465-9
101. Joint Formulary Committee. Centrally acting antihypertensive drugs. In: Metha DK, executive editor. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2003: 86-7
102. White DP, Zwillich CW, Pickett CK, et al. Central sleep apnoea: improvement with acetazolamide therapy. Arch Intern Med 1982; 142: 1816-9
103. Tojima H, Kunitomo F, Kimura H, et al. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 1988; 43: 113-9
104. Cook W, Benich J, Wooten S. Indices of severity of obstructive sleep apnoea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989; 96: 262-6
105. Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnoea. Chest 1992; 101: 753-7
106. Jelev A, Sood S, Liu H, et al. Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol 2001; 532: 467-81
107. Horner RL. The neuropharmacology of upper airway motor control in the awake and asleep states: implications for obstructive sleep apnoea. Respir Res 2001; 2: 286-94
108. Ishizuka T, Sakamoto Y, Sakurai T, et al. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 2003; 339: 143-6
109. Pack AI, Black JE, Schwartz JRL, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnoea. Am J Respir Crit Care Med 2001; 164: 1675-81